Marc Penicaud

Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.

Oakbio, Inc. creates technologies that transform carbon emissions from harmful waste into products. The company was founded by Brian Sefton and is headquartered in Sunnyvale, CA.

NeuClone Pty Ltd. develops biological products. It provides NeuMAX, a platform technology for manufacturing protein therapeutics. The firm offers cell lines engineering services for manufacturing biological drugs. The company was founded by Noelle Sunstrom in 2007 and is headquartered in Sydney, Australia.

Business/Higher Education Round Table Ltd. is a non profit organization that builds the relationship between business and higher education. It is a forum comprising higher education, business, industry bodies, and research institutions. The company was founded by Ashley Goldsworthy in 1990 and is headquartered in East Melbourne, Australia.